Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients

Current Pharmaceutical Design

Volumn 14, Issue 26, 2008, Pages 2686-2692

  Iacoviello, Massimo ^a   Guida, P ^a   Guastamacchia, E ^a   Triggiani, V ^a   Forleo, C ^a   Catanzaro, R ^a   Cicala, M ^a   Basile, M ^a   Sorrentino, S ^a   Favale, S ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Chronic heart failure; Prognosis; Sub clinical hypothyroidism; Thyroid hormones

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN; LIOTHYRONINE; SODIUM; SPIRONOLACTONE; THYROTROPIN; THYROXINE;

ADULT; ADVERSE OUTCOME; AGED; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEART FAILURE; HEART TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SODIUM BLOOD LEVEL; THYROTROPIN BLOOD LEVEL;

AGED; CHRONIC DISEASE; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGRESSION ANALYSIS; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 57349145932     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208786264142     Document Type: Review

References (28)

1. Jessup M, Brozena S. Heart Failure. N Engl J Med 2003; 348: 2007-18.
2. Khand A, Gemmel I, Clark AL, Cleland JG. Is the prognosis of heart failure improving? J Am Coll Cardiol 2000; 36: 2284-6.
3. Dahlström U. Frequent non-cardiac comorbidities in patients with chronic heart failure. Eur J Heart Fail 2005; 7: 309-16.
4. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344: 501-9.
5. Dillmann WH. Cellular action of thyroid hormone on the heart. Thyroid 2002; 12: 447-52.
6. Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007; 116: 1725-35.
7. Hiroi Y, Kim HH, Ying H, Furuya F, Huang Z, Simoncini T, et al. Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci USA 2006; 103: 14104-9.
8. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: Beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003; 88: 3731-7.
9. Manowitz NR, Mayor GH, Klepper MJ, DeGroot LJ. Subclinical hypothyroidism and euthyroid sick syndrome in patients with moderate-to-severe congestive heart failure. Am J Ther 1996; 3: 797-801.
10. Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, et al. Low-T3 syndrome: A strong prognostic predictor of death in patients with heart disease. Circulation 2003; 107: 708-13.
11. Hamilton MA, Stevenson LW, Luu M, Walden JA. Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol 1990; 16: 91-5.
12. Pingitore A, Landi P, Taddei MC, Ripoli A, L'Abbate A, Iervasi G. Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 2005; 118: 132-6.
13. Kozdag G, Ural D, Vural A, Agacdiken A, Kahraman G, Sahin T, et al. Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy. Eur J Heart Fail 2005; 7: 113-8.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. American Society of Echocardiography's Nomenclature and Standards Committee; task force on chamber quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108.
15. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: A report from the Doppler quantification task force of the nomenclature and standards committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167-84.
16. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
17. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102: 203-10.
18. Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation 1996; 94: 2800-6.
19. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-21.
20. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002; 137: 904-14.
21. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-38.
22. Brabant G, Beck-Peccoz P, Jarzab B, Laurberg P, Orgiazzi J, Szabolcs I, et al. Is there a need to redefine the upper normal limit of TSH? Eur J Endocrinol 2006; 154: 633-7.
23. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab 2007; 92: 1715-23.
24. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13: 3-126.
25. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: Time for a different approach. J Heart Lung Transplant 1994; 13: S107-S112.
26. Jandeleit-Dahm K, Cooper ME. The role of AGEs in cardiovascular disease. Curr Pharm Des 2008; 14(10): 979-86.
27. Robertson JH, Iga AM, Sales KM, Winslet MC, Seifalian AM. Integrins: A method of early intervention in the treatment of colorectal liver metastases. Curr Pharm Des 2008; 14(3): 296-305.
28. Vignati G, Annoni G. Characterization of supraventricular tachycardia in infants: Clinical and instrumental diagnosis. Curr Pharm Des 2008; 14(8): 729-35.